首页> European Journal of Haematology> Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

导出原文传递

翻译打印收藏纠错

第一作者： Lee,J.-H.

作者： Lee,J.-H. ^[1] ; Kim,D.-Y. ; Kim,S.-D. ; Choi,Y. ; Kang,Y.-A. ; Seol,M. ; Lee,K.-H.

作者单位： Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine ^[1]

关键词 Autologous stem cell transplantation Multiple myeloma PS-341/bortezomib adriamycin and dexamethasone

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European Journal of Haematology

2012年88卷6期

478-484页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

European Journal of Haematology

2012年88卷6期

478-484页

检索历史清除

Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

European Journal of Haematology

相似文献

同项目论文

European Journal of Haematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

European Journal of Haematology

相似文献

同项目论文

European Journal of Haematology

相关期刊

检索历史清除